Posts

EPIGENOMICS IN PUBLIC HEALTH

Image
“𝓓𝓝𝓐 𝓲𝓼𝓷’𝓽 𝓻𝓮𝓪𝓵𝓵𝔂 𝓵𝓲𝓴𝓮 𝓽𝓱𝓪𝓽. 𝓘𝓽’𝓼 𝓶𝓸𝓻𝓮 𝓵𝓲𝓴𝓮 𝓪 𝓼𝓬𝓻𝓲𝓹𝓽… 𝓲𝓭𝓮𝓷𝓽𝓲𝓬𝓪𝓵 𝓼𝓽𝓪𝓻𝓽𝓲𝓷𝓰 𝓹𝓸𝓲𝓷𝓽𝓼, 𝓭𝓲𝓯𝓯𝓮𝓻𝓮𝓷𝓽 𝓸𝓾𝓽𝓬𝓸𝓶𝓮𝓼.” - Nessa Carey 🧬 Epigenomics is reshaping how public health understands disease risk. Unlike genetic mutations, epigenomic changes alter gene expression without changing the DNA sequence, offering a powerful explanation for how environment, lifestyle, and social exposures become biologically embedded.            🔹 From diet, chronic stress, pollution, toxins, and infections to early-life exposures, these influences can modify DNA methylation, histone marks, and chromatin accessibility; ultimately affecting susceptibility to obesity, diabetes, cancer, cardiovascular disease, and neurodevelopmental disorders.            🔹 Epigenomics is advancing public health by clarifying gene-environment inter...

EPIGENETIC THERAPIES IN MEDICINE: PRECISION TREATMENT FRONTIER

Image
“𝓗𝓲𝓰𝓱-𝓽𝓱𝓻𝓸𝓾𝓰𝓱𝓹𝓾𝓽 𝓹𝓻𝓸𝓯𝓲𝓵𝓲𝓷𝓰 𝓪𝓵𝓵𝓸𝔀𝓼 𝓾𝓼 𝓽𝓸 𝓼𝔂𝓼𝓽𝓮𝓶𝓪𝓽𝓲𝓬𝓪𝓵𝓵𝔂 𝓭𝓲𝓼𝓬𝓸𝓿𝓮𝓻 𝓮𝓹𝓲𝓰𝓮𝓷𝓮𝓽𝓲𝓬 𝓭𝓻𝓾𝓰 𝓻𝓮𝓼𝓹𝓸𝓷𝓼𝓮𝓼.” - Anne Carpenter 🧬 Medicine is entering a precision era where epigenetics is redefining disease status and treatment. Unlike static genetic mutations, epigenetic modifications are dynamic, reversible, and influenced by environmental & developmental factors, positioning them as powerful levers for therapeutic intervention.           🔹 Epigenetic regulation operates through interconnected mechanisms, including DNA methylation, histone modification, & non-coding RNAs. These processes orchestrate gene expression patterns that determine cellular identity & function. Disruptions in these systems are strongly implicated in complex diseases such as cancer, neurodegenerative disorders, and cardiovascular conditions, where aberrant epigenetic marks can silence tumor suppressor genes or activ...

EPIGENETICS IN CANCER INITIATION 🎗️

Image
“𝓐𝓰𝓮-𝓪𝓼𝓼𝓸𝓬𝓲𝓪𝓽𝓮𝓭 𝓮𝓹𝓲𝓰𝓮𝓷𝓮𝓽𝓲𝓬 𝓬𝓱𝓪𝓷𝓰𝓮𝓼 𝓶𝓪𝔂 𝓹𝓻𝓲𝓶𝓮 𝓬𝓮𝓵𝓵𝓼 𝓯𝓸𝓻 𝓶𝓪𝓵𝓲𝓰𝓷𝓪𝓷𝓽 𝓽𝓻𝓪𝓷𝓼𝓯𝓸𝓻𝓶𝓪𝓽𝓲𝓸𝓷 𝓵𝓸𝓷𝓰 𝓫𝓮𝓯𝓸𝓻𝓮 𝓶𝓾𝓽𝓪𝓽𝓲𝓸𝓷𝓼 𝓪𝓬𝓬𝓾𝓶𝓾𝓵𝓪𝓽𝓮.” - Professor Anne Brunet 🧬 Epigenetics (heritable changes in gene expression without DNA sequence alteration) is increasingly recognized as a driver of early cancer initiation, not just a downstream effect. It shapes cellular identity, yet its dysregulation can quietly reprogram cells toward malignancy.           🔹 Aberrant hypermethylation silences tumor suppressor genes, while global hypomethylation promotes genomic instability and oncogene activation. These early shifts often precede detectable mutations, suggesting epigenetic “priming.”           🔹 Altered acetylation and methylation reshape chromatin accessibility, tipping the balance toward proliferation and away from apoptosis (key hallmarks of early tumorigenesis). ...

EPIGENETIC REPROGRAMMING DURING DEVELOPMENT

Image
“𝓒𝓮𝓵𝓵 𝓯𝓪𝓽𝓮 𝓭𝓮𝓬𝓲𝓼𝓲𝓸𝓷𝓼 𝓲𝓷 𝓮𝓪𝓻𝓵𝔂 𝓮𝓶𝓫𝓻𝔂𝓸𝓼 𝓪𝓻𝓮 𝓽𝓲𝓰𝓱𝓽𝓵𝔂 𝓵𝓲𝓷𝓴𝓮𝓭 𝓽𝓸 𝓬𝓱𝓪𝓷𝓰𝓮𝓼 𝓲𝓷 𝓬𝓱𝓻𝓸𝓶𝓪𝓽𝓲𝓷 𝓪𝓷𝓭 𝓮𝓹𝓲𝓰𝓮𝓷𝓮𝓽𝓲𝓬 𝓼𝓽𝓪𝓽𝓮𝓼.” - Magdalena Zernicka-Goetz  🧬 Epigenetic reprogramming is a central mechanism that resets gene regulation during early development. Rather than altering DNA sequence, epigenetic mechanisms (DNA methylation, histone modification, and chromatin remodeling) control when and how genes are expressed. This regulatory flexibility allows genetically identical cells to differentiate into diverse tissues while maintaining genomic stability.            🔹 A defining feature of mammalian development is the global remodeling of DNA methylation patterns after fertilization. The paternal genome undergoes rapid active demethylation, whereas the maternal genome experiences passive demethylation during early cleavage stages. This epigenetic reset enables the zygote to regain totipo...

HISTONE MODIFICATIONS & THE HISTONE CODE: THE LANGUAGE OF CHROMATIN REGULATION

Image
“𝓖𝓮𝓷𝓮𝓽𝓲𝓬𝓼 𝓹𝓻𝓸𝓿𝓲𝓭𝓮𝓼 𝓽𝓱𝓮 𝓵𝓪𝓷𝓰𝓾𝓪𝓰𝓮 𝓽𝓱𝓻𝓸𝓾𝓰𝓱 𝔀𝓱𝓲𝓬𝓱 𝓭𝓲𝓼𝓮𝓪𝓼𝓮𝓼 𝓬𝓪𝓷 𝓫𝓮 𝓾𝓷𝓭𝓮𝓻𝓼𝓽𝓸𝓸𝓭 𝓪𝓽 𝓽𝓱𝓮 𝓶𝓸𝓵𝓮𝓬𝓾𝓵𝓪𝓻 𝓵𝓮𝓿𝓮𝓵.” - Dr. Proma Chakraborty 🧬 Gene expression is not controlled by DNA sequence alone. A major regulatory layer lies within chromatin architecture, where histone modifications shape genome accessibility and transcriptional outcomes. Histones package DNA into nucleosomes but also serve as regulatory platforms through post-translational modifications (PTMs) including acetylation, methylation, phosphorylation, ubiquitination, and sumoylation.             🔹 Key regulatory effects include: • Acetylation (e.g., H3K9ac); neutralizes lysine charge, loosens chromatin, and promotes transcription. • Methylation, context-dependent; H3K4me3 marks active promoters, whereas H3K27me3 is linked to gene repression. • Phosphorylation; associated with DNA repair, chromatin remodeling, and mitosis. ...

UNDERSTANDING ACMG GUIDELINES & CLINICAL CLASSIFICATION OF GENETIC VARIANTS

Image
“𝓝𝓸 𝓼𝓲𝓷𝓰𝓵𝓮 𝓵𝓪𝓫𝓸𝓻𝓪𝓽𝓸𝓻𝔂 𝓱𝓪𝓼 𝓮𝓷𝓸𝓾𝓰𝓱 𝓭𝓪𝓽𝓪; 𝓬𝓸𝓵𝓵𝓪𝓫𝓸𝓻𝓪𝓽𝓲𝓿𝓮 𝓬𝓾𝓻𝓪𝓽𝓲𝓸𝓷 𝓲𝓼 𝓽𝓱𝓮 𝓯𝓾𝓽𝓾𝓻𝓮 𝓸𝓯 𝓰𝓮𝓷𝓸𝓶𝓲𝓬 𝓶𝓮𝓭𝓲𝓬𝓲𝓷𝓮.” - Professor Heidi Rehm 🧬 Genomic medicine has moved from discovery to daily clinical decision-making. At the center of this shift are the 2015 standards from the American College of Medical Genetics & Genomics (ACMG), which established a structured framework for interpreting sequence variants.    🔹 Genetic variants influence disease risk, diagnosis, prognosis, & therapeutic strategy. Without standardized interpretation, clinical decisions become inconsistent. The ACMG/AMP framework addresses this by integrating multiple evidence streams into five categories: 1. Pathogenic (Class 5) 2. Likely Pathogenic (Class 4) 3. Variant of Uncertain Significance [VUS] (Class 3) 4. Likely Benign (Class 2) 5. Benign (Class 1) This tiered system reduces interpretive subjectivity & improves reproducibility...

CHROMOSOMAL DISORDERS: TRISOMIES AND DELETIONS

Image
“𝓣𝓸 𝓾𝓷𝓭𝓮𝓻𝓼𝓽𝓪𝓷𝓭 𝓽𝓱𝓮 𝓸𝓻𝓰𝓪𝓷𝓲𝓼𝓶, 𝓸𝓷𝓮 𝓶𝓾𝓼𝓽 𝓾𝓷𝓭𝓮𝓻𝓼𝓽𝓪𝓷𝓭 𝓲𝓽𝓼 𝓬𝓱𝓻𝓸𝓶𝓸𝓼𝓸𝓶𝓮𝓼 𝓲𝓷 𝓽𝓱𝓮𝓲𝓻 𝓷𝓸𝓻𝓶𝓪𝓵 𝓼𝓽𝓪𝓽𝓮 𝓪𝓷𝓭 𝔀𝓱𝓮𝓷 𝓻𝓮𝓪𝓻𝓻𝓪𝓷𝓰𝓮𝓭.” - Barbara McClintock 🧬 Chromosomal disorders arise from abnormalities in chromosome number or structure, disrupting gene dosage and developmental pathways. Among them, trisomies & deletions are clinically and biologically significant due to their impact on embryogenesis, neurodevelopment, and long-term health.      🔹 Down syndrome (Trisomy 21) is the most prevalent autosomal trisomy compatible with postnatal survival. It is characterized by intellectual disability, congenital heart defects, endocrine dysfunction, and increased leukemia & early-onset Alzheimer risk. Other severe trisomies include: • Edwards syndrome • Patau syndrome These conditions often result in profound multisystem anomalies & high neonatal mortality. Most trisomies arise from meiotic nondisjun...